Effects of aryl substituents on the anti-HIV activity of the arylphosphoramidate derivatives of stavudine

Antiviral Chemistry and Chemotherapy

Volumn 13, Issue 3, 2002, Pages 197-203

  Uckun, Fatih M ^a   Samuel, P ^a   Qazi, S ^a   Chen, C ^a   Pendergrass, S ^a   Venkatachalam, T K ^a  

^a Parker Hughes Cancer Center   (United States)

Author keywords

AIDS; Aryl phosphate; d4T; HIV; Hydrolysis

Indexed keywords

PHOSPHORAMIDIC ACID DERIVATIVE; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG DERIVATIVE;

ALKALINITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; ELECTRON; HUMAN; HUMAN CELL; HYDROLYSIS; LIPOPHILICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; MONONUCLEAR CELL; PH; PHYSIOLOGY; VIROLOGY;

ANTI-HIV AGENTS; CELLS, CULTURED; HIV; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; LEUKOCYTES, MONONUCLEAR; MOLECULAR STRUCTURE; STAVUDINE; VIRUS REPLICATION;

EID: 0012615748     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020201300306     Document Type: Article

References (11)

1. Balzarini, J, Heredewijn, P, De Clercq E (1989). Differential patterns of intracellular metabolism of 2′,3′-didhydro-2′,3′- dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. Journal of Biological Chemistry 264:6127-6133.
2. Greene WC (1991). The molecular biology of human immunodeficiency virus Type-1 infections. New England Journal of Medicine 324:308-317.
3. McIntee EJ, Remmel RP, Schinazi RF, Abraham TW & Wagner CR (1997). Probing the mechanism of action and decomposition of aminoacid phosphomonoester amidates of antiviral necleoside prodrugs. Journal of Medicinal Chemistry 40:3323-3331.
4. Sepkowitz KA (2001). AIDS the first 20 years. New England Journal of Medicine 344:1764-1772.
5. Siddiqui AQ, McGuigan C, Ballatore C, Zuccotto F, Gilbert IH, De Clercq E & Balzarini J (1999). Journal of Medicinal Chemistry 42:4122-4128.
6. Uckun FM, Chelstrom LM, Tuel-Ahlgren L, Dibirdik I, Irvin JD, Chandan-Langlie M & Myers DE. (1998). TXU(Anti-CD7)-Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency Virus. Antimicrobial Agents and Chemotherapy 42:383-388.
7. Uckun FM & Vig R (2000) Aryl phosphate derivatives of D4T having anti-HIV activity. US Patent Number 6,030,957. Issue date: 2-29-2000. US Patent Number 6,350,736. Issue date: 2-26-2002.
8. Uckun FM, Qazi S, Pendergrass S, Venkatachalam TK, Mao C, Richman D (2002) Stampidine is a potent inhibitor of NRTI-resistant primary clinical HIV-1 isolates with B- and non-B subtypes. Antimicrobial Agents and Chemotherapy (in press).
9. Uckun FM, Chen CL, Lisowski E, Mitcheltree GC, Venkatachalam TK, Erbeck D, Chen H & Waurzyniak (2002) Toxicity and pharmacokinetics of stampidine in mice and rats. Arzneimittelforschung Drug Research (in press).
10. Venkatachalam TK, Tai HL, Vig R, Chen CL, Jan S & Uckun F (1998). Enhanced effects of a mono-bromo substitution at the para position of the phenyl moiety on the metabolism and anti-HIV activity of D4T-phenyl methoxyalaninyl phosphate derivatives. Biorganic Medicinal Chemistry Letters 8:3121.
11. Vig R, Venkatachalam T K & Uckun FM (1998). D4T-5′-[p- bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent. Antiviral chemistry and Chemotherapy 9:445.